0
Editor's Correspondence |

Triglyceride Level: A Predictive Risk Factor for Atherosclerosis?—Reply

Andrew L. Avins, MD, MPH; John M. Neuhaus, PhD
Arch Intern Med. 2001;161(2):296. doi:.
Text Size: A A A
Published online

Extract

In reply

We thank Dr Whayne and Ms Zielke for their comments. With respect to measuring triglyceride levels to identify patients who may be at risk for developing pancreatitis (eg, those with triglyceride levels >22.6 mmol/L [>2000 mg/dL]), it is not certain whether mass screening for this purpose is warranted. It is not clear how much risk of pancreatitis is present in patients with extreme elevations of triglyceride levels nor what proportion of these patients might be identified by the presence of associated physical findings (eg, eruptive xanthomas).1 Certainly, healthy lifestyle changes associated with lower triglyceride levels can always be advocated. However, measuring triglyceride levels to guide drug therapy of hypercholesterolemia seems unnecessary if a statin will be used because all statins lower triglyceride levels with no danger of exacerbating hypertriglyceridemia.2 Further research may identify a subfraction of lipoprotein species that provides important information about CHD risk. Currently, however, the simple fasting triglyceride level that most clinical laboratories measure has yet to be proven to provide essential clinical information. Until better data supporting the value of measuring and treating moderate levels of hypertriglyceridemia become available, clinicians would do best to concentrate on the many proven methods for estimating and reducing the risk of CHD.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles
Jobs
JAMAevidence.com

Users' Guides to the Medical Literature
Clinical Scenario

Users' Guides to the Medical Literature
In contrast, the authors of the Clopidogrel Versus Aspirin in Patients at Risk of Ischaemic...

brightcove.createExperiences();